Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Remedi SeniorCare
BALTIMORE, Aug. 28, 2014 /PRNewswire/ -- Remedi SeniorCare, one of the nation's largest providers of long-term care pharmacy services, has named Jennifer L. Hardesty, PharmD, FASCP as the Chief Clinical Officer of Remedi SeniorCare.
In this role, Dr. Hardesty is responsible for the continued development and implementation of the clinical programs for the company, as well as providing direction and standard reporting tools for Remedi's Consultant Pharmacists. Additionally, Dr. Hardesty will work closely with the CEO to ensure that the organization's operational and clinical plans will reinforce Remedi SeniorCare as a recognized leader in clinical programs and pharmacy operations in the markets served.
"Jennifer has a strong record of success leading and managing the clinical functions at our organization since 2006, making her an ideal choice for our Chief Clinical Officer," said Jeffrey Stamps, Remedi's President and Chief Executive Officer.
Dr. Hardesty has held clinical leadership roles at Remedi SeniorCare. Prior to this position, she was the Director of Clinical Services for the Mid-Atlantic Region and Corporate Compliance Officer. A fellow of ASCP, Dr. Hardesty actively lectures and writes on clinical and regulatory topics for local and national audiences. She received her doctorate in pharmacy from the University of Maryland School of Pharmacy, and she completed a Specialized Geriatrics Residency at the Peter Lamy Center for Drug Therapy and Aging.
About Remedi SeniorCare:
Remedi SeniorCare, a leading-edge institutional pharmacy, enables long-term care facilities to deliver better business results and provide exceptional resident-centered care. At the forefront of implementing high-tech advancements for the industry, Remedi has redefined medication administration and management with the launch of the Paxit® automated medication dispensing system, delivering superior accuracy, efficiency and medication cost reduction. Remedi's online and electronic tools – My Remedi® web portal and Connexit™ electronic data interchange – further drive business management efficiency and overall cost reduction. Remedi supports more than 34,000 residents across nine states and Washington, D.C. with superior customer service, ensuring prompt access to medication delivery, expertise and comprehensive support. For more information, visit www.RemediRx.com.
©2012 PR Newswire. All Rights Reserved.